nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—Pigmentation disorder—Cyclosporine—focal segmental glomerulosclerosis	0.059	0.0648	CcSEcCtD
Zuclopenthixol—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.0324	0.0356	CcSEcCtD
Zuclopenthixol—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0289	0.0317	CcSEcCtD
Zuclopenthixol—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0273	0.03	CcSEcCtD
Zuclopenthixol—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.0251	0.0276	CcSEcCtD
Zuclopenthixol—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.0227	0.025	CcSEcCtD
Zuclopenthixol—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.0224	0.0246	CcSEcCtD
Zuclopenthixol—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.019	0.0209	CcSEcCtD
Zuclopenthixol—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.0178	0.0196	CcSEcCtD
Zuclopenthixol—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.0176	0.0194	CcSEcCtD
Zuclopenthixol—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.0172	0.0189	CcSEcCtD
Zuclopenthixol—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.0163	0.0179	CcSEcCtD
Zuclopenthixol—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.016	0.0176	CcSEcCtD
Zuclopenthixol—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.0154	0.0169	CcSEcCtD
Zuclopenthixol—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.0153	0.0168	CcSEcCtD
Zuclopenthixol—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.0152	0.0167	CcSEcCtD
Zuclopenthixol—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.0151	0.0166	CcSEcCtD
Zuclopenthixol—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.0148	0.0163	CcSEcCtD
Zuclopenthixol—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.0142	0.0156	CcSEcCtD
Zuclopenthixol—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.0141	0.0155	CcSEcCtD
Zuclopenthixol—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0129	0.0142	CcSEcCtD
Zuclopenthixol—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.012	0.0132	CcSEcCtD
Zuclopenthixol—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0127	CcSEcCtD
Zuclopenthixol—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.0112	0.0124	CcSEcCtD
Zuclopenthixol—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.0112	0.0123	CcSEcCtD
Zuclopenthixol—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0111	0.0122	CcSEcCtD
Zuclopenthixol—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.0107	0.0118	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.0104	0.0114	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00976	0.0107	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00971	0.0107	CcSEcCtD
Zuclopenthixol—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00969	0.0107	CcSEcCtD
Zuclopenthixol—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00952	0.0105	CcSEcCtD
Zuclopenthixol—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00921	0.0101	CcSEcCtD
Zuclopenthixol—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00897	0.00986	CcSEcCtD
Zuclopenthixol—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00883	0.00971	CcSEcCtD
Zuclopenthixol—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00866	0.00952	CcSEcCtD
Zuclopenthixol—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.0086	0.00946	CcSEcCtD
Zuclopenthixol—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00848	0.00932	CcSEcCtD
Zuclopenthixol—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00844	0.00928	CcSEcCtD
Zuclopenthixol—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00836	0.00919	CcSEcCtD
Zuclopenthixol—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00811	0.00891	CcSEcCtD
Zuclopenthixol—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00806	0.00886	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00798	0.00878	CcSEcCtD
Zuclopenthixol—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00791	0.00869	CcSEcCtD
Zuclopenthixol—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00776	0.00853	CcSEcCtD
Zuclopenthixol—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00773	0.0085	CcSEcCtD
Zuclopenthixol—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.0077	0.00847	CcSEcCtD
Zuclopenthixol—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00745	0.0082	CcSEcCtD
Zuclopenthixol—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00743	0.00817	CcSEcCtD
Zuclopenthixol—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00732	0.00805	CcSEcCtD
Zuclopenthixol—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.0073	0.00802	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00727	0.008	CcSEcCtD
Zuclopenthixol—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00724	0.00796	CcSEcCtD
Zuclopenthixol—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00716	0.00788	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00702	0.00772	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00689	0.00757	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00687	0.00756	CcSEcCtD
Zuclopenthixol—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00682	0.0075	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00679	0.00746	CcSEcCtD
Zuclopenthixol—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00669	0.00736	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0064	0.00703	CcSEcCtD
Zuclopenthixol—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00635	0.00698	CcSEcCtD
Zuclopenthixol—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.0063	0.00693	CcSEcCtD
Zuclopenthixol—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00626	0.00688	CcSEcCtD
Zuclopenthixol—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00624	0.00686	CcSEcCtD
Zuclopenthixol—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00618	0.0068	CcSEcCtD
Zuclopenthixol—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.0061	0.00671	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00606	0.00666	CcSEcCtD
Zuclopenthixol—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00605	0.00666	CcSEcCtD
Zuclopenthixol—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.006	0.0066	CcSEcCtD
Zuclopenthixol—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.006	0.0066	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00579	0.00636	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00574	0.00631	CcSEcCtD
Zuclopenthixol—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00555	0.0061	CcSEcCtD
Zuclopenthixol—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00555	0.0061	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00517	0.00569	CcSEcCtD
Zuclopenthixol—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00504	0.00554	CcSEcCtD
Zuclopenthixol—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00497	0.00546	CcSEcCtD
Zuclopenthixol—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.0048	0.00528	CcSEcCtD
Zuclopenthixol—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00464	0.0051	CcSEcCtD
Zuclopenthixol—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00446	0.00491	CcSEcCtD
Zuclopenthixol—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00443	0.00487	CcSEcCtD
Zuclopenthixol—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00442	0.00486	CcSEcCtD
Zuclopenthixol—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.0044	0.00484	CcSEcCtD
Zuclopenthixol—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00417	0.00459	CcSEcCtD
Zuclopenthixol—Thioproperazine—ALB—focal segmental glomerulosclerosis	0.00074	0.286	CrCbGaD
Zuclopenthixol—Thiothixene—ALB—focal segmental glomerulosclerosis	0.000728	0.281	CrCbGaD
Zuclopenthixol—Pipotiazine—ALB—focal segmental glomerulosclerosis	0.000728	0.281	CrCbGaD
Zuclopenthixol—Chlorpromazine—ALB—focal segmental glomerulosclerosis	0.000395	0.152	CrCbGaD
Zuclopenthixol—ADRA2A—Hemostasis—TRPC6—focal segmental glomerulosclerosis	0.000225	0.00256	CbGpPWpGaD
Zuclopenthixol—ADRA2A—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.000224	0.00254	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000222	0.00253	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000221	0.00251	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00022	0.0025	CbGpPWpGaD
Zuclopenthixol—DRD2—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.000218	0.00248	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	0.000217	0.00247	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000215	0.00245	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.000214	0.00244	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000211	0.00241	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000211	0.0024	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000211	0.0024	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00021	0.00239	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000209	0.00238	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000207	0.00236	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000205	0.00234	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000204	0.00233	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.0002	0.00228	CbGpPWpGaD
Zuclopenthixol—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000199	0.00226	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000198	0.00225	CbGpPWpGaD
Zuclopenthixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000195	0.00222	CbGpPWpGaD
Zuclopenthixol—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000195	0.00222	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.000192	0.00219	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000191	0.00218	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000191	0.00217	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00019	0.00216	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000188	0.00214	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000187	0.00213	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000186	0.00212	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000185	0.00211	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000182	0.00207	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000182	0.00207	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.000181	0.00206	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.00018	0.00205	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000179	0.00204	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000179	0.00204	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000178	0.00203	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.000178	0.00202	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000176	0.002	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000175	0.002	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00017	0.00194	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00017	0.00193	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00017	0.00193	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000169	0.00192	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000163	0.00186	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000161	0.00183	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00016	0.00182	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000159	0.00181	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000158	0.0018	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000158	0.0018	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000156	0.00178	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000156	0.00178	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000155	0.00177	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000155	0.00176	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000155	0.00176	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000153	0.00175	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000153	0.00174	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000152	0.00173	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000151	0.00172	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000149	0.0017	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000149	0.00169	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000148	0.00169	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000147	0.00167	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000146	0.00167	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000146	0.00166	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000146	0.00166	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000144	0.00164	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000144	0.00164	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000144	0.00164	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000143	0.00163	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.000142	0.00162	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000142	0.00162	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000142	0.00162	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000142	0.00161	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000141	0.00161	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000141	0.00161	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000141	0.0016	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000139	0.00158	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000138	0.00157	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000137	0.00156	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000136	0.00155	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000135	0.00154	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000135	0.00154	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000135	0.00153	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000134	0.00152	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000133	0.00151	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000132	0.0015	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000131	0.0015	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000131	0.00149	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000131	0.00149	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00013	0.00148	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00013	0.00148	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00013	0.00148	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000129	0.00147	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000128	0.00146	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000128	0.00146	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000124	0.00141	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000123	0.0014	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000121	0.00138	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000121	0.00137	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000119	0.00136	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000119	0.00136	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000119	0.00136	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000119	0.00135	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000119	0.00135	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000118	0.00135	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000117	0.00133	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000116	0.00132	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000116	0.00132	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000114	0.0013	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.000114	0.0013	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000114	0.00129	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000113	0.00129	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000113	0.00128	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000112	0.00128	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000112	0.00127	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000112	0.00127	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000111	0.00126	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00011	0.00126	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00011	0.00125	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00011	0.00125	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000109	0.00124	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000108	0.00124	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000108	0.00123	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000108	0.00123	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000107	0.00122	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000106	0.00121	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000104	0.00118	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000103	0.00117	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000103	0.00117	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000101	0.00115	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000101	0.00115	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000101	0.00115	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.0001	0.00114	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	9.92e-05	0.00113	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	9.87e-05	0.00112	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.43e-05	0.00107	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—LIPC—focal segmental glomerulosclerosis	9.4e-05	0.00107	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	9.35e-05	0.00106	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	9.31e-05	0.00106	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—ALB—focal segmental glomerulosclerosis	9.29e-05	0.00106	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	9.21e-05	0.00105	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	9.2e-05	0.00105	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	9.18e-05	0.00104	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—AGT—focal segmental glomerulosclerosis	9.14e-05	0.00104	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	9.01e-05	0.00103	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	8.63e-05	0.000982	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	8.54e-05	0.000973	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	8.52e-05	0.00097	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	8.5e-05	0.000967	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	8.47e-05	0.000964	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	8.44e-05	0.000961	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	8.41e-05	0.000957	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	8.39e-05	0.000955	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	8.38e-05	0.000954	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	8.37e-05	0.000953	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	8.36e-05	0.000952	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	8.33e-05	0.000949	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	8.32e-05	0.000947	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—CTGF—focal segmental glomerulosclerosis	8.28e-05	0.000942	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—LPL—focal segmental glomerulosclerosis	8.24e-05	0.000939	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	8.23e-05	0.000937	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	8.21e-05	0.000934	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	8.16e-05	0.000929	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	7.81e-05	0.000889	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	7.76e-05	0.000883	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	7.65e-05	0.000871	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	7.63e-05	0.000869	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	7.63e-05	0.000868	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.62e-05	0.000868	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	7.62e-05	0.000867	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	7.58e-05	0.000863	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	7.48e-05	0.000851	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.31e-05	0.000833	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	7.12e-05	0.000811	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.1e-05	0.000808	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—AGT—focal segmental glomerulosclerosis	7.05e-05	0.000803	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	7.03e-05	0.0008	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	7.01e-05	0.000798	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.99e-05	0.000796	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	6.95e-05	0.000791	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.86e-05	0.000781	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.72e-05	0.000765	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—FN1—focal segmental glomerulosclerosis	6.52e-05	0.000742	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.51e-05	0.000742	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.41e-05	0.00073	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.4e-05	0.000728	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	6.38e-05	0.000726	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	6.28e-05	0.000714	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	6.12e-05	0.000697	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.07e-05	0.000691	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	5.87e-05	0.000669	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	5.83e-05	0.000664	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	5.74e-05	0.000653	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.61e-05	0.000639	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.52e-05	0.000629	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.43e-05	0.000619	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	5.42e-05	0.000617	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.42e-05	0.000617	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	5.39e-05	0.000614	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.38e-05	0.000613	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.36e-05	0.00061	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	5.32e-05	0.000606	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.27e-05	0.0006	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.26e-05	0.000599	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	5.16e-05	0.000588	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	5.07e-05	0.000578	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.99e-05	0.000568	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.98e-05	0.000567	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.97e-05	0.000566	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.94e-05	0.000563	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	4.91e-05	0.000559	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.89e-05	0.000557	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	4.8e-05	0.000546	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.67e-05	0.000531	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.58e-05	0.000522	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	4.54e-05	0.000517	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.51e-05	0.000513	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.5e-05	0.000512	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.44e-05	0.000505	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.42e-05	0.000503	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.24e-05	0.000482	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.17e-05	0.000474	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.16e-05	0.000473	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.15e-05	0.000473	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	4.1e-05	0.000467	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	4.08e-05	0.000465	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.79e-05	0.000432	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	3.77e-05	0.000429	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	3.74e-05	0.000426	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.58e-05	0.000407	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.52e-05	0.000401	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.47e-05	0.000395	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.46e-05	0.000394	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.42e-05	0.00039	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.4e-05	0.000387	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	3.2e-05	0.000364	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	3.15e-05	0.000359	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.95e-05	0.000335	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.7e-05	0.000307	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.66e-05	0.000302	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.65e-05	0.000302	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.6e-05	0.000296	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	2.45e-05	0.000279	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.42e-05	0.000275	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.22e-05	0.000253	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.19e-05	0.000249	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.18e-05	0.000249	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.14e-05	0.000244	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.99e-05	0.000227	CbGpPWpGaD
